Bend, Oregon
United States
30
2025-01-30
The entities that hold a legal rights for patent applications filed by inventor West James William:
James William West from Bend, US has applied for patents for these inventions. The list has both pending applications and granted patents:
PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF MAKING AND USING THEREOF
#2 | 2024-12-05ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS OF USE THEREOF
#3 | 2024-07-11MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF
#4 | 2024-03-07ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHODS OF USE THEREOF
#5 | 2023-07-06MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#6 | 2023-01-19Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
#7 | 2022-12-01Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
#8 | 2022-10-18Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
#9 | 2022-09-22ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS OF USE THEREOF
#10 | 2022-07-28Protease-resistant systems for polypeptide display and methods of making and using thereof
#11 | 2021-11-18MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#12 | 2021-11-11MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#13 | 2021-09-16MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF
#14 | 2021-01-28Activatable antibodies that bind epidermal growth factor receptor and methods thereof
#15 | 2020-10-29Protease-resistant systems for polypeptide display and methods of making and using thereof
#16 | 2020-10-29ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS OF USE THEREOF
#17 | 2020-09-17Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
#18 | 2020-07-23Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
#19 | 2019-12-05ANTI-JAGGED 1/JAGGED 2 CROSS-REACTIVE ANTIBODIES, ACTIVATABLE ANTI-JAGGED ANTIBODIES AND METHODS OF USE THEREOF
#20 | 2019-08-08MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#21 | 2019-04-25Methods of treatment using activatable anti-EGFR antibodies
#22 | 2018-10-25CD147 ANTIBODIES, ACTIVATABLE CD147 ANTIBODIES, AND METHODS OF MAKING AND USE THEREOF
#23 | 2017-03-23Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
#24 | 2017-01-05Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
#25 | 2016-12-08Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
#26 | 2016-10-27Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof
#27 | 2016-10-06Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
#28 | 2016-09-15Protease-resistant systems for polypeptide display and methods of making and using thereof
#29 | 2016-08-11Anti-EGFR activatable antibodies
#30 | 2015-03-19Multispecific antibodies, multispecific activatable antibodies and methods of using the same
1102888 ⎘